Latest Immunogenicity Stories
Potential Human Immunogenicity Correlates Identified PRINCETON, N.J., March 11, 2015 /PRNewswire/ -- Soligenix, Inc.
LOS ANGELES, Feb. 18, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J.
PRINCETON, N.J., Jan. 29, 2015 /PRNewswire/ -- Soligenix, Inc.
PROVIDENCE, R.I., Dec.
The Webinar on November 12, 2014 will focus on two diverse approaches for using automated microscopy and image analysis to measure different and specific indicators of cellular stress leading
PROVIDENCE, R.I., Oct.
Full Article Here: http://bit.ly/CHOPPI_PR PROVIDENCE, R.I., July 8, 2014 /PRNewswire/ -- A Public-private partnership resulted in the development of a new web-based tool that will
-- 3SBio's pegsiticase has shown a promising efficacy and safety profile in early clinical trials and Selecta and 3SBio plan to advance clinical studies of pegsiticase-based treatments for refractory
In vivo T cell active immunotherapy generated from DCVex(TM) platform SEATTLE and SOUTH SAN FRANCISCO, Calif., June 5, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy
- Emitting flashes of light; glittering.